GBS (NASDAQ:GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced it has been awarded a USD $4.7
PTC Therapeutics Inc (NASDAQ:PTCT) entered into a strategic financing collaboration with Blackstone Inc (NYSE:BX). As part of the collaboration, Blackstone Life Sciences and…